IDE Now. Reimbursement Later. CMS Approval Can Be Critical for Sponsors
Find out why CMS approval and early data collection are essential to the success of any MedTech reimbursement strategy.
To begin, investigational device exemption (IDE) coverage can offset a number of clinical trial expenses. Of course, that is only the beginning. CMS data collection can support AMA CPT coding, help determine a product’s sell price, and provide more robust overhead analysis. Ultimately, seeking CMS approval and the resulting IDE coverage for your MedTech innovation is the best possible buffer against future reimbursement obstacles.
Review our fact sheet on what CMS approval can do for MedTech sponsors, then decide if you need to seek guidance on the execution of your next study.